Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial

被引：0
|
作者：
Xue Meng
Anping Zheng
Jun Wang
Xiaoyuan Wu
Guang Li
Jun Zhu
Hu Ma
Xiaodong Zhu
Anhui Shi
Chunhua Dai
Senxiang Yan
Buhai Wang
Zhongyu Qu
Chun Han
Xindong Sun
Ming Ye
Ruitai Fan
Niyazi Huerxidan
Xiaohong Wang
Jinming Yu
机构：
[1] Shandong Cancer Hospital and Institute,Department of Radiation Oncology
[2] Anyang Cancer Hospital,Department of Radiation Oncology
[3] The Fourth Hospital of Hebei Medical University,Department of Radiation Oncology
[4] Henan Cancer Hospital,Department of Radiation Oncology
[5] The First Hospital of China Medical University,Department of Radiation Oncology
[6] Jiangsu Cancer Hospital,Department of Radiation Oncology
[7] Affiliated Hospital of Zunyi Medical College,Department of Radiation Oncology
[8] Guangxi Medical University Cancer Hospital,Department of Radiation Oncology
[9] Beijing Cancer Hospital,Department of Radiation Oncology
[10] Affiliated Hospital of Jiangsu University,Department of Radiation Oncology
[11] The First Hospital of Zhejiang Province,Department of Radiation Oncology
[12] Yangzhou University,Department of Oncology, Subei People’s Hospital
[13] Henan Provincial Nanyang Central Hospital,Department of Medical Oncology
[14] Renji Hospital Shanghai jiaotong university School of medicine,Department of Radiation Oncology
[15] The First Affiliated Hospital of Zhengzhou University,Department of Radiation Oncology
[16] The First Affiliated Hospital of Xinjiang Medical University,Department of Oncology
[17] The First Affiliated Hospital of Henan University of Science and Technology,Department of Radiation Oncology
来源：
British Journal of Cancer | 2023年 / 129卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1787 / 1792
页数：5
相关论文
共 50 条
  • [1] Nimotuzumab plus concurrent chemo-radiotherapy in unresectable locally advanced oesophageal squamous cell carcinoma (ESCC): interim analysis from a Phase 3 clinical trial
    Meng, Xue
    Zheng, Anping
    Wang, Jun
    Wu, Xiaoyuan
    Li, Guang
    Zhu, Jun
    Ma, Hu
    Zhu, Xiaodong
    Shi, Anhui
    Dai, Chunhua
    Yan, Senxiang
    Wang, Buhai
    Qu, Zhongyu
    Han, Chun
    Sun, Xindong
    Ye, Ming
    Fan, Ruitai
    Huerxidan, Niyazi
    Wang, Xiaohong
    Yu, Jinming
    BRITISH JOURNAL OF CANCER, 2023, 129 (11) : 1787 - 1792
  • [2] Nimotuzumab plus concurrent chemo-radiotherapy versus chemo-radiotherapy in unresectable locally advanced esophageal squamous cell carcinoma (ESCC): Interim analysis from a prospective, randomized-controlled, double-blinded, multicenter, and phase III clinical trial (NXCEL1311 Study).
    Meng, Xue
    Zheng, Anping
    Wang, Jun
    Wang, Jianhua
    Li, Guang
    Zhu, Jun
    Ma, Hu
    Zhu, Xiaodong
    Shi, Anhui
    Dai, Chunhua
    Yan, Senxiang
    Wang, Buhai
    Qu, Zhongyu
    Han, Chun
    Sun, Xindong
    Ye, Ming
    Fan, Ruitai
    Huerxidan, Ni Yazi
    Wang, Xiaohong
    Yu, Jinming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [3] Nimotuzumab combined with concurrent chemo-radiotherapy in patients with locally advanced cervical squamous cell carcinoma: A randomized, controlled, open-label, multicenter study
    Wang, J.
    Jiang, P.
    Wei, L.
    Zou, L.
    Li, X.
    Wang, C.
    Sun, X.
    Ding, L.
    Yuan, X.
    Cheng, H.
    Wu, D.
    Cai, R.
    Yin, R.
    Zhang, J.
    Qiu, H.
    Wang, T.
    Gao, K.
    Zhuo, Y.
    Zhang, Y.
    Zhao, F.
    ANNALS OF ONCOLOGY, 2023, 34 : S518 - S519
  • [4] Concurrent chemo-radiotherapy in locally advanced NSCLC: Is it specially tailored for the squamous cell pathology?
    Chaudhuri, A.
    Cornelius, N.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S36 - S37
  • [5] Nimotuzumab Combined With Concurrent Chemoradiation Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma
    Zhai, Y. R.
    Hui, Z.
    Wang, X.
    Liang, J.
    Wang, W.
    Feng, Q.
    Zhou, Z.
    Wang, X.
    Xiao, Z.
    Bi, N.
    Wang, L.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E205 - E205
  • [6] An Open Label, Multicenter Clinical Study of Cetuximab Combined with Concurrent Chemo-radiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: Preliminary Results of a Phase II Trial
    Yu, J.
    Wang, J. H.
    Sun, X. D.
    Wang, L. H.
    Zhu, G. Y.
    Feng, P. B.
    Ye, M.
    Lu, Y.
    Zhu, S. C.
    Liao, Z. X.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S309 - S309
  • [7] Simultaneous integrated boost intensitymodulated radiotherapy (SIB-IMRT) combined with nimotuzumab for locally advanced esophageal squamous cell carcinoma (ESCC): A phase II clinical trial
    Wang, Lan
    Liu, Lihong
    Cao, Yu
    Chen, Xiaoxi
    Liu, Shutang
    Li, Xiaoning
    Han, Jing
    Wang, Qi
    Han, Chun
    BMC CANCER, 2024, 24 (01)
  • [8] Nimotuzumab plus concurrent chemoradiotherapy for locally advanced cervical squamous cell carcinoma: The randomized, phase 3 CC3 study
    Wang, Jun Jie
    Jiang, Ping
    Qu, Ang
    Wei, Lichun
    Zou, Lijuan
    Li, Xiaofan
    Wang, Chunyan
    Sun, Xiaoge
    Ding, Li
    Yuan, Xiangkun
    Cheng, Huijun
    Wu, Dehua
    Cai, Rong
    Yin, Rutie
    Zhang, Jidong
    Qiu, Hui
    Wang, Tiejun
    Gao, Kun
    Zhuo, Yanhong
    Zhang, Yun Yan
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [9] A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix
    Guangwen Yuan
    Lingying Wu
    Manni Huang
    Nan Li
    Jusheng An
    Radiation Oncology, 9
  • [10] A phase II study of concurrent chemo-radiotherapy with weekly nedaplatin in advanced squamous cell carcinoma of the uterine cervix
    Yuan, Guangwen
    Wu, Lingying
    Huang, Manni
    Li, Nan
    An, Jusheng
    RADIATION ONCOLOGY, 2014, 9
12345